Corbus Pharmaceuticals Holdi

Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.25

+0.18 (+1.98%)

As of Jul 4, 2:14 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +31.4% upside

Low Target $8.71

Average Target $12.15

High Target $17.60

Current Price $9.25

Current
$9.25

Target
$12.15

$8.71 $12.15 avg $17.60

Scenario Analysis

Bear Case

$8.71

-5.8%

Low target

Base Case

$12.15

+31.4%

Avg target

Bull Case

$17.60

+90.3%

High target

Risk/Reward

15.5x

Highly favorable

Price in Context

52-Week High

$20.56

-55.0% from high

52-Week Low

$7.12

+29.9% from low

Target vs 52W High

$12.15

-40.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	-1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-49.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+176.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-88.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-67.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.8%